Rare diseases
Investigational molecules
Locations
Back to Germany27 clinical trials in Langen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on heart failure prevention and treatment, including investigations of novel drug combinations for patients with reduced ejection fraction. Research extends to post-myocardial infarction care and cardiovascular death risk reduction.
Studies incorporate cutting-edge therapeutic approaches combining established treatments with new investigational medicines.
Comprehensive research programs targeting various types of breast cancer, including triple-negative, hormone receptor-positive, and HER2-positive disease states. Studies focus on both early-stage and metastatic conditions.
Investigations combine immunotherapy, targeted treatments, and conventional approaches to improve patient outcomes.
Research initiatives examining blood disorders and metabolic conditions, including studies on lymphoma and cholesterol management. Innovative approaches using artificial intelligence for treatment resistance prediction in polycythemia vera.
Studies aim to advance personalized treatment approaches and improve quality of life for patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
